ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Palonosetron Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-11L10576
Home | Market Reports | Health| Health Conditions| Cancer
Global and United States Palonosetron Market Report Forecast 2022 2028
BUY CHAPTERS

Global Palonosetron Market Research Report 2025

Code: QYRE-Auto-11L10576
Report
September 2025
Pages:92
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Helsinn Therapeutics
TEVA
Dr Reddys Laboratories
Cipla Ltd
Pfizer Inc
Sagent Pharmaceuticals
Fresenius Kabi
Qilu Pharmaceutical
Jiangsu Aosaikang Pharmaceutical
Sichuan Hairong Pharmaceutical
Exela Pharma

Palonosetron Market Size

The global market for Palonosetron was valued at US$ 120 million in the year 2024 and is projected to reach a revised size of US$ 159 million by 2031, growing at a CAGR of 4.1% during the forecast period.

Palonosetron Market

Palonosetron Market

Palonosetron (INN, trade name Aloxi) is a 5-HT3 antagonist used in the prevention and treatment of chemotherapy-induced nausea and vomiting (CINV).
Palonosetron is a medication used to prevent nausea and vomiting caused by chemotherapy and surgery. It belongs to a class of drugs called 5-HT3 receptor antagonists, which inhibit the action of serotonin, a chemical in the body that triggers nausea and vomiting. The increasing incidence of cancer worldwide is a major driver for the palonosetron market. As more and more patients undergo chemotherapy, there is a growing need to manage side effects such as nausea and vomiting. With growing awareness about cancer treatment, patients, caretakers, and healthcare providers are seeking better prevention and management of chemotherapy-induced side effects. This drives the demand for medications like palonosetron. Technological advancements in healthcare have led to better detection and treatment of cancer. This has resulted in increased adoption of chemotherapy, leading to a higher demand for medications like palonosetron. While palonosetron is effective, there are other medications available for managing chemotherapy-induced nausea and vomiting. Competition among different medications in the market can drive innovation, resulting in increased demand for palonosetron. Higher healthcare expenditure and accessibility to healthcare facilities in many regions further contribute to the growth of the palonosetron market.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Palonosetron, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Palonosetron.
The Palonosetron market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Palonosetron market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Palonosetron manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Palonosetron Market Report

Report Metric Details
Report Name Palonosetron Market
Accounted market size in year US$ 120 million
Forecasted market size in 2031 US$ 159 million
CAGR 4.1%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Injection 0.25 mg/5 mL
  • Injection 20 mcg/kg (max 1.5 mg)
Segment by Application
  • Adults
  • Children
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Helsinn Therapeutics, Teva, Dr. Reddys Laboratories, Cipla, Pfizer, Sagent Pharmaceuticals, Fresenius Kabi, Qilu Pharmaceutical, Jiangsu Aosaikang Pharmaceutical, Sichuan Hairong Pharmaceutical, Exela Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Palonosetron manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Palonosetron in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Palonosetron Market growing?

Ans: The Palonosetron Market witnessing a CAGR of 4.1% during the forecast period 2025-2031.

What is the Palonosetron Market size in 2031?

Ans: The Palonosetron Market size in 2031 will be US$ 159 million.

Who are the main players in the Palonosetron Market report?

Ans: The main players in the Palonosetron Market are Helsinn Therapeutics, Teva, Dr. Reddys Laboratories, Cipla, Pfizer, Sagent Pharmaceuticals, Fresenius Kabi, Qilu Pharmaceutical, Jiangsu Aosaikang Pharmaceutical, Sichuan Hairong Pharmaceutical, Exela Pharma

What are the Application segmentation covered in the Palonosetron Market report?

Ans: The Applications covered in the Palonosetron Market report are Adults, Children

What are the Type segmentation covered in the Palonosetron Market report?

Ans: The Types covered in the Palonosetron Market report are Injection 0.25 mg/5 mL, Injection 20 mcg/kg (max 1.5 mg)

Recommended Reports

Cancer Therapy Drugs

Cancer Treatment Devices

Specialty Cancer Treatments

1 Palonosetron Market Overview
1.1 Product Definition
1.2 Palonosetron by Type
1.2.1 Global Palonosetron Market Value Comparison by Type (2024 VS 2031)
1.2.2 Injection 0.25 mg/5 mL
1.2.3 Injection 20 mcg/kg (max 1.5 mg)
1.3 Palonosetron by Application
1.3.1 Global Palonosetron Market Value by Application (2024 VS 2031)
1.3.2 Adults
1.3.3 Children
1.4 Global Palonosetron Market Size Estimates and Forecasts
1.4.1 Global Palonosetron Revenue 2020-2031
1.4.2 Global Palonosetron Sales 2020-2031
1.4.3 Global Palonosetron Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Palonosetron Market Competition by Manufacturers
2.1 Global Palonosetron Sales Market Share by Manufacturers (2020-2025)
2.2 Global Palonosetron Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Palonosetron Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Palonosetron, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Palonosetron, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Palonosetron, Product Type & Application
2.7 Global Key Manufacturers of Palonosetron, Date of Enter into This Industry
2.8 Global Palonosetron Market Competitive Situation and Trends
2.8.1 Global Palonosetron Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Palonosetron Players Market Share by Revenue
2.8.3 Global Palonosetron Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Palonosetron Market Scenario by Region
3.1 Global Palonosetron Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Palonosetron Sales by Region: 2020-2031
3.2.1 Global Palonosetron Sales by Region: 2020-2025
3.2.2 Global Palonosetron Sales by Region: 2026-2031
3.3 Global Palonosetron Revenue by Region: 2020-2031
3.3.1 Global Palonosetron Revenue by Region: 2020-2025
3.3.2 Global Palonosetron Revenue by Region: 2026-2031
3.4 North America Palonosetron Market Facts & Figures by Country
3.4.1 North America Palonosetron Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Palonosetron Sales by Country (2020-2031)
3.4.3 North America Palonosetron Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Palonosetron Market Facts & Figures by Country
3.5.1 Europe Palonosetron Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Palonosetron Sales by Country (2020-2031)
3.5.3 Europe Palonosetron Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Palonosetron Market Facts & Figures by Region
3.6.1 Asia Pacific Palonosetron Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Palonosetron Sales by Region (2020-2031)
3.6.3 Asia Pacific Palonosetron Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Palonosetron Market Facts & Figures by Country
3.7.1 Latin America Palonosetron Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Palonosetron Sales by Country (2020-2031)
3.7.3 Latin America Palonosetron Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Palonosetron Market Facts & Figures by Country
3.8.1 Middle East and Africa Palonosetron Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Palonosetron Sales by Country (2020-2031)
3.8.3 Middle East and Africa Palonosetron Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Palonosetron Sales by Type (2020-2031)
4.1.1 Global Palonosetron Sales by Type (2020-2025)
4.1.2 Global Palonosetron Sales by Type (2026-2031)
4.1.3 Global Palonosetron Sales Market Share by Type (2020-2031)
4.2 Global Palonosetron Revenue by Type (2020-2031)
4.2.1 Global Palonosetron Revenue by Type (2020-2025)
4.2.2 Global Palonosetron Revenue by Type (2026-2031)
4.2.3 Global Palonosetron Revenue Market Share by Type (2020-2031)
4.3 Global Palonosetron Price by Type (2020-2031)
5 Segment by Application
5.1 Global Palonosetron Sales by Application (2020-2031)
5.1.1 Global Palonosetron Sales by Application (2020-2025)
5.1.2 Global Palonosetron Sales by Application (2026-2031)
5.1.3 Global Palonosetron Sales Market Share by Application (2020-2031)
5.2 Global Palonosetron Revenue by Application (2020-2031)
5.2.1 Global Palonosetron Revenue by Application (2020-2025)
5.2.2 Global Palonosetron Revenue by Application (2026-2031)
5.2.3 Global Palonosetron Revenue Market Share by Application (2020-2031)
5.3 Global Palonosetron Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Helsinn Therapeutics
6.1.1 Helsinn Therapeutics Company Information
6.1.2 Helsinn Therapeutics Description and Business Overview
6.1.3 Helsinn Therapeutics Palonosetron Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Helsinn Therapeutics Palonosetron Product Portfolio
6.1.5 Helsinn Therapeutics Recent Developments/Updates
6.2 Teva
6.2.1 Teva Company Information
6.2.2 Teva Description and Business Overview
6.2.3 Teva Palonosetron Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Teva Palonosetron Product Portfolio
6.2.5 Teva Recent Developments/Updates
6.3 Dr. Reddys Laboratories
6.3.1 Dr. Reddys Laboratories Company Information
6.3.2 Dr. Reddys Laboratories Description and Business Overview
6.3.3 Dr. Reddys Laboratories Palonosetron Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Dr. Reddys Laboratories Palonosetron Product Portfolio
6.3.5 Dr. Reddys Laboratories Recent Developments/Updates
6.4 Cipla
6.4.1 Cipla Company Information
6.4.2 Cipla Description and Business Overview
6.4.3 Cipla Palonosetron Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Cipla Palonosetron Product Portfolio
6.4.5 Cipla Recent Developments/Updates
6.5 Pfizer
6.5.1 Pfizer Company Information
6.5.2 Pfizer Description and Business Overview
6.5.3 Pfizer Palonosetron Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Pfizer Palonosetron Product Portfolio
6.5.5 Pfizer Recent Developments/Updates
6.6 Sagent Pharmaceuticals
6.6.1 Sagent Pharmaceuticals Company Information
6.6.2 Sagent Pharmaceuticals Description and Business Overview
6.6.3 Sagent Pharmaceuticals Palonosetron Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Sagent Pharmaceuticals Palonosetron Product Portfolio
6.6.5 Sagent Pharmaceuticals Recent Developments/Updates
6.7 Fresenius Kabi
6.7.1 Fresenius Kabi Company Information
6.7.2 Fresenius Kabi Description and Business Overview
6.7.3 Fresenius Kabi Palonosetron Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Fresenius Kabi Palonosetron Product Portfolio
6.7.5 Fresenius Kabi Recent Developments/Updates
6.8 Qilu Pharmaceutical
6.8.1 Qilu Pharmaceutical Company Information
6.8.2 Qilu Pharmaceutical Description and Business Overview
6.8.3 Qilu Pharmaceutical Palonosetron Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Qilu Pharmaceutical Palonosetron Product Portfolio
6.8.5 Qilu Pharmaceutical Recent Developments/Updates
6.9 Jiangsu Aosaikang Pharmaceutical
6.9.1 Jiangsu Aosaikang Pharmaceutical Company Information
6.9.2 Jiangsu Aosaikang Pharmaceutical Description and Business Overview
6.9.3 Jiangsu Aosaikang Pharmaceutical Palonosetron Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Jiangsu Aosaikang Pharmaceutical Palonosetron Product Portfolio
6.9.5 Jiangsu Aosaikang Pharmaceutical Recent Developments/Updates
6.10 Sichuan Hairong Pharmaceutical
6.10.1 Sichuan Hairong Pharmaceutical Company Information
6.10.2 Sichuan Hairong Pharmaceutical Description and Business Overview
6.10.3 Sichuan Hairong Pharmaceutical Palonosetron Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Sichuan Hairong Pharmaceutical Palonosetron Product Portfolio
6.10.5 Sichuan Hairong Pharmaceutical Recent Developments/Updates
6.11 Exela Pharma
6.11.1 Exela Pharma Company Information
6.11.2 Exela Pharma Description and Business Overview
6.11.3 Exela Pharma Palonosetron Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Exela Pharma Palonosetron Product Portfolio
6.11.5 Exela Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Palonosetron Industry Chain Analysis
7.2 Palonosetron Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Palonosetron Production Mode & Process Analysis
7.4 Palonosetron Sales and Marketing
7.4.1 Palonosetron Sales Channels
7.4.2 Palonosetron Distributors
7.5 Palonosetron Customer Analysis
8 Palonosetron Market Dynamics
8.1 Palonosetron Industry Trends
8.2 Palonosetron Market Drivers
8.3 Palonosetron Market Challenges
8.4 Palonosetron Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Helsinn Therapeutics
TEVA
Dr Reddys Laboratories
Cipla Ltd
Pfizer Inc
Sagent Pharmaceuticals
Fresenius Kabi
Qilu Pharmaceutical
Jiangsu Aosaikang Pharmaceutical
Sichuan Hairong Pharmaceutical
Exela Pharma
List of Tables
 Table 1. Global Palonosetron Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Palonosetron Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Palonosetron Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Palonosetron Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Palonosetron Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Palonosetron Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Palonosetron Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Palonosetron Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Palonosetron, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Palonosetron, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Palonosetron, Product Type & Application
 Table 12. Global Key Manufacturers of Palonosetron, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Palonosetron by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Palonosetron as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Palonosetron Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Palonosetron Sales by Region (2020-2025) & (K Units)
 Table 18. Global Palonosetron Sales Market Share by Region (2020-2025)
 Table 19. Global Palonosetron Sales by Region (2026-2031) & (K Units)
 Table 20. Global Palonosetron Sales Market Share by Region (2026-2031)
 Table 21. Global Palonosetron Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Palonosetron Revenue Market Share by Region (2020-2025)
 Table 23. Global Palonosetron Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Palonosetron Revenue Market Share by Region (2026-2031)
 Table 25. North America Palonosetron Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Palonosetron Sales by Country (2020-2025) & (K Units)
 Table 27. North America Palonosetron Sales by Country (2026-2031) & (K Units)
 Table 28. North America Palonosetron Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Palonosetron Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Palonosetron Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Palonosetron Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Palonosetron Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Palonosetron Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Palonosetron Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Palonosetron Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Palonosetron Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Palonosetron Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Palonosetron Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Palonosetron Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Palonosetron Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Palonosetron Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Palonosetron Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Palonosetron Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Palonosetron Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Palonosetron Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Palonosetron Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Palonosetron Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Palonosetron Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Palonosetron Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Palonosetron Sales (K Units) by Type (2020-2025)
 Table 51. Global Palonosetron Sales (K Units) by Type (2026-2031)
 Table 52. Global Palonosetron Sales Market Share by Type (2020-2025)
 Table 53. Global Palonosetron Sales Market Share by Type (2026-2031)
 Table 54. Global Palonosetron Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Palonosetron Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Palonosetron Revenue Market Share by Type (2020-2025)
 Table 57. Global Palonosetron Revenue Market Share by Type (2026-2031)
 Table 58. Global Palonosetron Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Palonosetron Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Palonosetron Sales (K Units) by Application (2020-2025)
 Table 61. Global Palonosetron Sales (K Units) by Application (2026-2031)
 Table 62. Global Palonosetron Sales Market Share by Application (2020-2025)
 Table 63. Global Palonosetron Sales Market Share by Application (2026-2031)
 Table 64. Global Palonosetron Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Palonosetron Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Palonosetron Revenue Market Share by Application (2020-2025)
 Table 67. Global Palonosetron Revenue Market Share by Application (2026-2031)
 Table 68. Global Palonosetron Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Palonosetron Price (USD/Unit) by Application (2026-2031)
 Table 70. Helsinn Therapeutics Company Information
 Table 71. Helsinn Therapeutics Description and Business Overview
 Table 72. Helsinn Therapeutics Palonosetron Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. Helsinn Therapeutics Palonosetron Product
 Table 74. Helsinn Therapeutics Recent Developments/Updates
 Table 75. Teva Company Information
 Table 76. Teva Description and Business Overview
 Table 77. Teva Palonosetron Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. Teva Palonosetron Product
 Table 79. Teva Recent Developments/Updates
 Table 80. Dr. Reddys Laboratories Company Information
 Table 81. Dr. Reddys Laboratories Description and Business Overview
 Table 82. Dr. Reddys Laboratories Palonosetron Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. Dr. Reddys Laboratories Palonosetron Product
 Table 84. Dr. Reddys Laboratories Recent Developments/Updates
 Table 85. Cipla Company Information
 Table 86. Cipla Description and Business Overview
 Table 87. Cipla Palonosetron Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Cipla Palonosetron Product
 Table 89. Cipla Recent Developments/Updates
 Table 90. Pfizer Company Information
 Table 91. Pfizer Description and Business Overview
 Table 92. Pfizer Palonosetron Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. Pfizer Palonosetron Product
 Table 94. Pfizer Recent Developments/Updates
 Table 95. Sagent Pharmaceuticals Company Information
 Table 96. Sagent Pharmaceuticals Description and Business Overview
 Table 97. Sagent Pharmaceuticals Palonosetron Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. Sagent Pharmaceuticals Palonosetron Product
 Table 99. Sagent Pharmaceuticals Recent Developments/Updates
 Table 100. Fresenius Kabi Company Information
 Table 101. Fresenius Kabi Description and Business Overview
 Table 102. Fresenius Kabi Palonosetron Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. Fresenius Kabi Palonosetron Product
 Table 104. Fresenius Kabi Recent Developments/Updates
 Table 105. Qilu Pharmaceutical Company Information
 Table 106. Qilu Pharmaceutical Description and Business Overview
 Table 107. Qilu Pharmaceutical Palonosetron Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 108. Qilu Pharmaceutical Palonosetron Product
 Table 109. Qilu Pharmaceutical Recent Developments/Updates
 Table 110. Jiangsu Aosaikang Pharmaceutical Company Information
 Table 111. Jiangsu Aosaikang Pharmaceutical Description and Business Overview
 Table 112. Jiangsu Aosaikang Pharmaceutical Palonosetron Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 113. Jiangsu Aosaikang Pharmaceutical Palonosetron Product
 Table 114. Jiangsu Aosaikang Pharmaceutical Recent Developments/Updates
 Table 115. Sichuan Hairong Pharmaceutical Company Information
 Table 116. Sichuan Hairong Pharmaceutical Description and Business Overview
 Table 117. Sichuan Hairong Pharmaceutical Palonosetron Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 118. Sichuan Hairong Pharmaceutical Palonosetron Product
 Table 119. Sichuan Hairong Pharmaceutical Recent Developments/Updates
 Table 120. Exela Pharma Company Information
 Table 121. Exela Pharma Description and Business Overview
 Table 122. Exela Pharma Palonosetron Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 123. Exela Pharma Palonosetron Product
 Table 124. Exela Pharma Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. Palonosetron Distributors List
 Table 128. Palonosetron Customers List
 Table 129. Palonosetron Market Trends
 Table 130. Palonosetron Market Drivers
 Table 131. Palonosetron Market Challenges
 Table 132. Palonosetron Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Palonosetron
 Figure 2. Global Palonosetron Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Palonosetron Market Share by Type: 2024 & 2031
 Figure 4. Injection 0.25 mg/5 mL Product Picture
 Figure 5. Injection 20 mcg/kg (max 1.5 mg) Product Picture
 Figure 6. Global Palonosetron Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Palonosetron Market Share by Application: 2024 & 2031
 Figure 8. Adults
 Figure 9. Children
 Figure 10. Global Palonosetron Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Palonosetron Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Palonosetron Sales (2020-2031) & (K Units)
 Figure 13. Global Palonosetron Average Price (USD/Unit) & (2020-2031)
 Figure 14. Palonosetron Report Years Considered
 Figure 15. Palonosetron Sales Share by Manufacturers in 2024
 Figure 16. Global Palonosetron Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Palonosetron Players: Market Share by Revenue in Palonosetron in 2024
 Figure 18. Palonosetron Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Palonosetron Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Palonosetron Sales Market Share by Country (2020-2031)
 Figure 21. North America Palonosetron Revenue Market Share by Country (2020-2031)
 Figure 22. U.S. Palonosetron Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Palonosetron Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Palonosetron Sales Market Share by Country (2020-2031)
 Figure 25. Europe Palonosetron Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Palonosetron Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Palonosetron Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Palonosetron Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Palonosetron Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Palonosetron Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Palonosetron Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Palonosetron Revenue Market Share by Region (2020-2031)
 Figure 33. China Palonosetron Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Palonosetron Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Palonosetron Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Palonosetron Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Palonosetron Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Taiwan Palonosetron Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Indonesia Palonosetron Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Thailand Palonosetron Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Malaysia Palonosetron Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Philippines Palonosetron Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Palonosetron Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Palonosetron Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Palonosetron Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Palonosetron Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Palonosetron Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Palonosetron Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Palonosetron Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Palonosetron Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Palonosetron Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. U.A.E Palonosetron Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Palonosetron by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Palonosetron by Type (2020-2031)
 Figure 55. Global Palonosetron Price (USD/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Palonosetron by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Palonosetron by Application (2020-2031)
 Figure 58. Global Palonosetron Price (USD/Unit) by Application (2020-2031)
 Figure 59. Palonosetron Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Global Palonosetron HCl API Market Research Report 2024
Global Netupitant and Palonosetron Hydrochloride Capsules Market Research Report 2024
Global Palonosetron Hydrochloride Injection Market Research Report 2025
Palonosetron HCI Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Netupitant Palonosetron FDC Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Palonosetron Hydrochloride Market Research Report 2024
Palonosetron Hydrochloride API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Chemotherapy induced Nausea and Vomiting Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Chemotherapy Induced Nausea and Vomiting CINV Drugs Market Insights Forecast to 2030
Global Ramosetron Market Research Report 2024
Global Chemotherapy induced Nausea and Vomiting Treatment Market Research Report 2025
Global Treatment of Chemotherapy Induced Nausea in Cancer Patients Market Research Report 2025
Global Chemotheraphy Induced Nausea and Vomitting CINV Drugs Market Insights Forecast to 2030
Trisenox Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Arsenic Trioxide Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Arranon Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Ondansetron Hydrochloride Injection Market Research Report 2024
Global Granisetron HCl API Market Research Report 2024
Nitazoxanide Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Granisetron Market Insights Forecast to 2030

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-5L19798
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Cancer Insurance Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28I6901
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22R9736
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Drugs for Differentiated Thyroid Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29A2598
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions